Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M65,546Revenue $M21,848Net Margin (%)9.1Z-Score3.9
Enterprise Value $M65,906EPS $1.6Operating Margin %12.5F-Score7
P/E(ttm))28.7Cash Flow Per Share $6.7Pre-tax Margin (%)12.1Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %-1.2Quick Ratio1.6Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %-22.9Current Ratio1.9Lower Leverage y-yN
Price/Cash Flow9.8y-y EBITDA Growth Rate %55.0ROA % (ttm)5.5Higher Current Ratio y-yY
Dividend Yield %2.0Insider Buy (3m)0ROE % (ttm)10.0Less Shares Outstanding y-yY
Payout Ratio %52.0Shares Outstanding M1,504ROI % (ttm)9.7Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTJean-Marie Eveillard 2014-06-30 Buy 0.16%$37.02 - $41
($39.24)
$ 43.5911%New holding, 1665688 sh.1,665,688
ABTKen Fisher 2014-06-30 Add$37.02 - $41
($39.24)
$ 43.5911%Add 106.12%18,027
ABTGeorge Soros 2014-06-30 Reduce-0.11%$37.02 - $41
($39.24)
$ 43.5911%Reduce -23.73%932,181
ABTRichard Pzena 2014-03-31 Add0.11%$35.85 - $40.12
($38.5)
$ 43.5913%Add 7.9%6,934,282
ABTGeorge Soros 2014-03-31 Add0.1%$35.85 - $40.12
($38.54)
$ 43.5913%Add 25.97%1,222,181
ABTRay Dalio 2014-03-31 Buy 0.01%$35.85 - $40.12
($38.54)
$ 43.5913%New holding, 17200 sh.17,200
ABTDaniel Loeb 2014-03-31 Sold Out -2.1%$35.85 - $40.12
($38.54)
$ 43.5913%Sold Out0
ABTDaniel Loeb 2013-12-31 Buy 2.1%$33.01 - $38.71
($36.89)
$ 43.5918%New holding, 3250000 sh.3,250,000
ABTRobert Olstein 2013-12-31 Add0.19%$33.01 - $38.71
($36.89)
$ 43.5918%Add 23.45%179,000
ABTMario Gabelli 2013-12-31 Add0.02%$33.01 - $38.71
($36.89)
$ 43.5918%Add 110.21%197,183
ABTRay Dalio 2013-12-31 Sold Out -0.03%$33.01 - $38.71
($36.89)
$ 43.5918%Sold Out0
ABTRichard Pzena 2013-09-30 Add0.46%$32.93 - $36.88
($35.12)
$ 43.5924%Add 49.22%6,449,283
ABTPRIMECAP Management 2013-09-30 Add0.19%$32.93 - $36.88
($35.12)
$ 43.5924%Add 36.9%16,188,865
ABTRay Dalio 2013-09-30 Buy 0.03%$32.93 - $36.88
($35.12)
$ 43.5924%New holding, 118700 sh.118,700
ABTKen Fisher 2013-09-30 Reduce$32.93 - $36.88
($35.12)
$ 43.5924%Reduce -21.02%8,439
ABTMason Hawkins 2013-09-30 Reduce-0.12%$32.93 - $36.88
($35.12)
$ 43.5924%Reduce -4.79%13,727,856
ABTJohn Hussman 2013-06-30 Sold Out -0.52%$34.88 - $38.56
($36.68)
$ 43.5919%Sold Out0
ABTVanguard Health Care Fund 2013-06-30 Reduce-0.24%$34.88 - $38.56
($36.68)
$ 43.5919%Reduce -18.79%7,591,400
ABTRobert Olstein 2013-03-31 Buy 0.8%$31.34 - $35.32
($33.84)
$ 43.5929%New holding, 129000 sh.129,000
ABTRichard Pzena 2013-03-31 Add0.62%$31.34 - $35.32
($33.84)
$ 43.5929%Add 127.45%4,434,735
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABT Jean-Marie Eveillard 2014-06-301,665,6880.110.16New Buy
ABT Ken Fisher 2014-06-3018,02700+106.12%
ABT Richard Pzena 2014-06-307,197,6910.481.6+3.8%
ABT Ray Dalio 2014-06-3017,70000.01+2.91%
ABT PRIMECAP Management 2014-06-3017,127,0631.140.77+0.23%
ABT Robert Bruce 2014-06-30229,3000.022.2
ABT Robert Olstein 2014-06-30182,0000.011
ABT Vanguard Health Care Fund 2014-06-307,591,4000.50.82
ABT Dodge & Cox 2014-06-3036,89800-0.14%
ABT Mason Hawkins 2014-06-3013,687,8770.913-0.43%
ABT Mario Gabelli 2014-06-30160,7070.010.03-4.62%
ABT George Soros 2014-06-30932,1810.060.29-23.73%
Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Foltz Charles DSenior Vice President 2014-03-03Sell1,588$38.959.73view
Mason Heather LSenior Vice President 2014-03-03Sell2,196$38.959.73view
Blaser Brian JExecutive Vice President 2014-03-03Sell1,441$39.019.56view
ASHLEY RICHARD WExecutive Vice President 2014-03-03Sell2,098$399.59view
ALLEN HUBERT LExecutive Vice President 2014-03-03Sell1,543$39.039.51view
Funck Robert EVice President, Controller 2014-03-03Sell1,413$38.979.67view
FREYMAN THOMAS CExecutive Vice President 2014-03-03Sell2,984$39.19.31view
Contreras JaimeSenior Vice President 2014-03-03Sell8,081$39.378.56view
Warmuth Michael JExecutive Vice President 2014-03-03Sell16,484$39.019.56view
Doyle Katherine C.Senior Vice President 2014-03-03Sell6,639$39.019.56view

Press Releases about ABT :

    Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    Sure Bets: Slow-Changing Industries for Long-Term Investors Oct 01 2014 
    Market Indicators That Could Spell Trouble for Investors Sep 29 2014 
    Medical Technology Company Offers Investment Opportunity Sep 25 2014 
    Weekly 52-Week Highs Highlight: ABT, SWK, LMT, AMGN Sep 13 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Abbott: A Brighter Future Aug 28 2014 
    6 Stocks Currently Trading Below Fair Value Jul 02 2014 
    Why I Bought Baxter International Jun 19 2014 
    Two Stocks On My Watch List For June 2014 May 29 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 

    More From Our Partners
    Benzinga's M&A Chatter for Wednesday October 29, 2014 Oct 29 2014 - BENZINGA

    More From Other Websites
    INDIA PRESS-Johnson & Johnson may buy electrolyte drink ORS-L for 7 bln rupees - Times of India Oct 29 2014
    [$$] Abbott Labs to Buy Topera Oct 29 2014
    The Zacks Analyst Blog Highlights: AbbVie, Mylan, Abbott Laboratories, Actavis and Mallinckrodt Oct 29 2014
    9:32 am Abbott Labs expands its medical device business with acquisition in catheter-based... Oct 29 2014
    Abbott Expands Its Medical Device Business with Acquisition in Catheter-Based Electrophysiology... Oct 29 2014
    Deutsche Bank Upgrades Abbott Laboratories Oct 29 2014
    Amgen Q3 Earnings Beat Estimates; Guidance Mixed Oct 27 2014
    Here's what companies were saying about the economy this week Oct 24 2014
    Abbott Laboratories (ABT) Earnings Report: Q3 2014 Conference Call Transcript Oct 23 2014
    [$$] Abbott Sales Rise 5.8%; Mylan Terms Revised Oct 22 2014
    Biogen, Thermo Reports Disappoint; Abbott Accelerates Oct 22 2014
    Abbott, Mylan silent on why changing tax-inversion terms Oct 22 2014
    Abbott Laboratories Conference Call Highlights Oct 22 2014
    Mylan-Abbott Inversion Deal Is On… With Some Changes Oct 22 2014
    Today's Unusual Social Activity Stock: Abbott Laboratories (ABT) Oct 22 2014
    Abbott Labs' (ABT) Earnings Up Y/Y in Q3, Guidance Updated Oct 22 2014
    Abbott, Mylan back generics deal, tweak terms after tax rule change Oct 22 2014
    Abbott Laboratories Earnings Call scheduled for 9:00 am ET today Oct 22 2014
    ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 22 2014
    Abbott says third-quarter sales match forecasts Oct 22 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK